Paradiso A - Search Results

1

Ifosfamide plus mitoxantrone as salvage treatment in non-Hodgkin's lymphomas.

Lorusso V, Paradiso A, Guida M, Berardi F, De Lena M. Lorusso V, et al. Among authors: paradiso a. Am J Clin Oncol. 1991 Dec;14(6):492-5. doi: 10.1097/00000421-199112000-00007. Am J Clin Oncol. 1991. PMID: 1957837

2

Prognostic relevance of ploidy and proliferative activity evaluation by flow cytometry in poor prognosis non-Hodgkin's lymphomas.

De Lena M, Barletta A, Marzullo F, Lorusso V, Berardi F, Tommasi S, Mangia A, Paradiso A. De Lena M, et al. Among authors: paradiso a. Haematologica. 1992 Jan-Feb;77(1):84-6. Haematologica. 1992. PMID: 1398287

3

M-VECA (methotrexate, vinblastine, epidoxorubicin and carboplatin) in the treatment of advanced urothelial carcinoma.

Lorusso V, Berardi F, Brandi M, Mastria A, Paradiso A, Catino AM, Tatulli C, De Lena M. Lorusso V, et al. Among authors: paradiso a. Tumori. 1993 Jun 30;79(3):191-4. doi: 10.1177/030089169307900306. Tumori. 1993. PMID: 8236502 Clinical Trial.

4

Carboplatin plus ifosfamide as salvage treatment of epithelial ovarian cancer: a pilot study.

Lorusso V, Catino A, Leone B, Rabinovich M, Gargano G, Paradiso A, De Lena M. Lorusso V, et al. Among authors: paradiso a. J Clin Oncol. 1993 Oct;11(10):1952-6. doi: 10.1200/JCO.1993.11.10.1952. J Clin Oncol. 1993. PMID: 8410121

5

Mitoxantrone, L-leucovorin and 5-fluorouracil: an effective and well tolerated first-line treatment for advanced breast cancer.

Lorusso V, Mancarella S, Catino A, Brandi M, Paradiso A, Latorre A, Mastria A, De Mitrio A, Guida M, De Lena M. Lorusso V, et al. Among authors: paradiso a. Tumori. 1999 Jan-Feb;85(1):60-4. doi: 10.1177/030089169908500113. Tumori. 1999. PMID: 10228500

6

Randomized clinical trial of adjuvant fluorouracil, epirubicin, and cyclophosphamide chemotherapy for patients with fast-proliferating, node-negative breast cancer.

Paradiso A, Schittulli F, Cellamare G, Mangia A, Marzullo F, Lorusso V, De Lena M. Paradiso A, et al. J Clin Oncol. 2001 Oct 1;19(19):3929-37. doi: 10.1200/JCO.2001.19.19.3929. J Clin Oncol. 2001. PMID: 11579113 Clinical Trial.

7

Sequential alternate administration of tamoxifen and medroxyprogesterone acetate in advanced breast cancer: clinical-biological randomized study.

De Lena M, Tommasi S, Schittulli F, Lorusso V, Paradiso A. De Lena M, et al. Among authors: paradiso a. Tumori. 1990 Apr 30;76(2):190-5. doi: 10.1177/030089169007600208. Tumori. 1990. PMID: 2139523 Clinical Trial.

8

Tumor-proliferative activity, progesterone receptor status, estrogen receptor level, and clinical outcome of estrogen receptor-positive advanced breast cancer.

Paradiso A, Tommasi S, Mangia A, Lorusso V, Simone G, De Lena M. Paradiso A, et al. Cancer Res. 1990 May 15;50(10):2958-62. Cancer Res. 1990. PMID: 2334898

9

Correlation between ERICA and DCC assay in hormone receptor assessment of human breast cancer.

De Lena M, Marzullo F, Simone G, Labriola A, Tommasi S, Petroni S, Paradiso A. De Lena M, et al. Among authors: paradiso a. Oncology. 1988;45(4):308-12. doi: 10.1159/000226629. Oncology. 1988. PMID: 2455257

10

Intravenous administration of cyclophosphamide, methotrexate and 5-fluorouracil in metastatic breast cancer. A pilot study.

De Lena M, Brandi M, Logroscino A, Lorusso V, Paradiso A, Maiello E. De Lena M, et al. Among authors: paradiso a. Tumori. 1988 Feb 29;74(1):57-63. doi: 10.1177/030089168807400110. Tumori. 1988. PMID: 3162624

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

467 results

Search Page

Filters